Galectin Therapeutics
GALT
GALT
73 hedge funds and large institutions have $21.6M invested in Galectin Therapeutics in 2024 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
19% more capital invested
Capital invested by funds: $18.2M → $21.6M (+$3.4M)
3% more ownership
Funds ownership: 12.32% → 15.32% (+3%)
Holders
73
Holding in Top 10
–
Calls
$2.24M
Puts
$7K
Top Buyers
| 1 | +$2.59M | |
| 2 | +$1.12M | |
| 3 | +$834K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$414K |
| 5 |
State Street
Boston,
Massachusetts
|
+$207K |
Top Sellers
| 1 | -$479K | |
| 2 | -$422K | |
| 3 | -$165K | |
| 4 |
Jane Street
New York
|
-$87.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$72K |